By NOF, Washington, DC; Thursday, March 19, 2009

National Osteoporosis Foundation's 8th International Symposium April 1-5, 2009 at Marriott Wardman Park Hotel

Washington, DC (March 19, 2009) – The National Osteoporosis Foundation (NOF) will bring together a faculty of internationally-renowned experts to share clinically relevant evidence-based information on bone health and osteoporosis prevention, diagnosis and treatment with hundreds of healthcare professionals at its comprehensive annual five-day conference in Washington, DC.


NOF’s  8th International Symposium on Osteoporosis (ISO8): “Translating Research Into Clinical Practice,” will help health professionals improve their clinical management of patients with osteoporosis at a variety of in-depth educational sessions, such as: Secondary Causes of Bone Loss; Bone Quality: New Imaging to Refine Fracture Risk and Improve Therapy; and Emerging Pharmaceutical Therapies: Denosumab and New EAAs.


EVENT:

8th International Symposium on Osteoporosis:
Translating Clinical Research Into Practice

WHEN:

April 1-5, 2009

FEATURED 
SPEAKER:

Peter Cavanagh, PhD, DSc, University of Washington Medical Center
Thursday, April 2 at 8:00 a.m.
Topic: Lessons from Space Travel for Improving Bone Health on Earth

WHERE:

Marriott Wardman Park Hotel
2660 Woodley Road, NW
Washington, DC 20008

For the complete conference agenda, list of speakers, session topics and times, please visit the NOF Web site at www.nof.org. For pre-conference interviews, information and media registration, please contact Heather Rabinowitz at (202) 721-6359.

####

Celebrating its 25th anniversary, the National Osteoporosis Foundation is the nation’s leading voluntary health organization solely dedicated to osteoporosis and bone health. Our mission is to prevent osteoporosis, to promote lifelong bone health, to help improve the lives of those affected by osteoporosis and related fractures, and to find a cure. For more information on osteoporosis and bone health, contact NOF online at www.nof.org or by telephone (800) 223-9994.

According to NOF prevalence estimates and reinforced in Bone Health and Osteoporosis: A Report of the Surgeon General, osteoporosis is a major public health threat for an estimated 44 million Americans, or 55 percent of the people 50 years of age and older. In the United States today, 10 million individuals are estimated to already have the disease. Almost 34 million more people are estimated to have low bone mass, placing them at increased risk for osteoporosis. Of the 10 million Americans estimated to have osteoporosis, eight million are women and two million are men. One in two women and one in four men age 50 and older will have an osteoporosis-related fracture in her or his lifetime.

The latest

Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.

In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."

CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.